Shuai Li

CDK4/6 Inhibition Augments Antitumor Immunity by Enhancing T-cell Activation

Jiehui Deng, Eric S. Wang, Russell W. Jenkins et al. · Cancer Discovery · 2017 · 741 citations · Full text

Mechanisms and clinical activity of an EGFR and HER2 exon 20–selective kinase inhibitor in non–small cell lung cancer

Jacqulyne Robichaux, Yasir Y. Elamin, Zhi Tan et al. · Nature Medicine · 2018 · 443 citations · Full text

Tumor Biology, Oncology, Kinase Inhibitor +12

Avoiding dynastic, assortative mating, and population stratification biases in Mendelian randomization through within-family analyses

Ben Brumpton, Eleanor Sanderson, Karl Heilbron et al. · Nature Communications · 2020 · 403 citations · Full text

Within-sibship genome-wide association analyses decrease bias in estimates of direct genetic effects

Laurence J Howe, Michel G. Nivard, Tim Morris et al. · Nature Genetics · 2022 · 372 citations · Full text

KRAS Dimerization Impacts MEK Inhibitor Sensitivity and Oncogenic Activity of Mutant KRAS

Chiara Ambrogio, Jens Köhler, Zhi-Wei Zhou et al. · Cell · 2018 · 281 citations · Full text

Oncogenic Activity, Receptor Tyrosine Kinase, Mutant Kras +3